{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:00:33Z","timestamp":1740135633168,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1245\/s10434-024-15304-x","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T12:01:58Z","timestamp":1714737718000},"page":"5361-5369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Top Peritoneal Surface Malignancy Articles from 2022 to Inform your Cancer Practice"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-1424","authenticated-orcid":false,"given":"Harveshp","family":"Mogal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"issue":"2","key":"15304_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies. Cancer. 2000;88(2):358\u201363. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(20000115)88:2%3c358::AID-CNCR16%3e3.0.CO;2-O.","journal-title":"Cancer."},{"issue":"3","key":"15304_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.6363","volume":"156","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Barretta F, Yonemura Y, et al. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. JAMA Surg. 2021;156(3):e206363. https:\/\/doi.org\/10.1001\/jamasurg.2020.6363.","journal-title":"JAMA Surg."},{"issue":"4","key":"15304_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/XCS.0000000000000091","volume":"234","author":"ME Lundy","year":"2022","unstructured":"Lundy ME, Moaven O, Perry KC, et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Cancer with Peritoneal Dissemination: 30 Years of Experience at a Single Institution. J Am Coll Surg. 2022;234(4):546\u201356. https:\/\/doi.org\/10.1097\/XCS.0000000000000091.","journal-title":"J Am Coll Surg."},{"issue":"6","key":"15304_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S1470-2045(17)30336-4","volume":"18","author":"J Tseng","year":"2017","unstructured":"Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. Lancet Oncol. 2017;18(6):711\u20132. https:\/\/doi.org\/10.1016\/S1470-2045(17)30336-4.","journal-title":"Lancet Oncol."},{"key":"15304_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21037\/tgh.2019.08.03","volume":"4","author":"A Guner","year":"2019","unstructured":"Guner A, Yildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol. 2019;4:58. https:\/\/doi.org\/10.21037\/tgh.2019.08.03.","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"9","key":"15304_CR6","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen HC, Wang X, et al. Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy. Ann Surg Oncol. 2017;24(9):2679\u201387. https:\/\/doi.org\/10.1245\/s10434-017-5838-y.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"15304_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, Ejaz A, Kim Y, et al. Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis. J Am Coll Surg. 2014;219(4):664\u201375. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.03.062.","journal-title":"J Am Coll Surg."},{"issue":"3","key":"15304_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10120-021-01268-4","volume":"25","author":"A Agnes","year":"2022","unstructured":"Agnes A, Biondi A, Persiani R, et al. Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer. Gastric Cancer. 2022;25(3):629\u201339. https:\/\/doi.org\/10.1007\/s10120-021-01268-4.","journal-title":"Gastric Cancer."},{"issue":"2","key":"15304_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jso.25959","volume":"122","author":"A Agnes","year":"2020","unstructured":"Agnes A, Biondi A, Laurino A, et al. A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer. J Surg Oncol. 2020;122(2):293\u2013305. https:\/\/doi.org\/10.1002\/jso.25959.","journal-title":"J Surg Oncol."},{"issue":"1","key":"15304_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","volume":"22","author":"C Mariette","year":"2019","unstructured":"Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W, de Manzoni G. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer. 2019;22(1):1\u20139. https:\/\/doi.org\/10.1007\/s10120-018-0868-0.","journal-title":"Gastric Cancer."},{"issue":"5","key":"15304_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000443506","volume":"90","author":"N Charalampakis","year":"2016","unstructured":"Charalampakis N, Nogueras Gonz\u00e1lez GM, Elimova E, et al. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation. Oncology. 2016;90(5):239\u201347. https:\/\/doi.org\/10.1159\/000443506.","journal-title":"Oncology."},{"issue":"2","key":"15304_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cas.14231","volume":"111","author":"QY Chen","year":"2020","unstructured":"Chen QY, Zhong Q, Zhou JF, et al. Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study. Cancer Sci. 2020;111(2):502\u201312. https:\/\/doi.org\/10.1111\/cas.14231.","journal-title":"Cancer Sci."},{"issue":"2","key":"15304_CR13","first-page":"130","volume":"41","author":"Y Yonemura","year":"1994","unstructured":"Yonemura Y, Sugiyama K, Fujimura T, et al. A new surgical technique (left upper abdominal evisceration) for advanced carcinoma of the gastric stump. Hepatogastroenterology. 1994;41(2):130\u20133.","journal-title":"Hepatogastroenterology."},{"issue":"13","key":"15304_CR14","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1245\/s10434-016-5409-7","volume":"23","author":"N Ikoma","year":"2016","unstructured":"Ikoma N, Blum M, Chiang YJ, et al. Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Ann Surg Oncol. 2016;23(13):4332\u20137. https:\/\/doi.org\/10.1245\/s10434-016-5409-7.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"15304_CR15","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1245\/s10434-014-3525-9","volume":"21","author":"K Takebayashi","year":"2014","unstructured":"Takebayashi K, Murata S, Yamamoto H, et al. Surgery-Induced Peritoneal Cancer Cells in Patients Who Have Undergone Curative Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2014;21(6):1991\u20137. https:\/\/doi.org\/10.1245\/s10434-014-3525-9.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"15304_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10120-013-0306-2","volume":"17","author":"JH Lee","year":"2014","unstructured":"Lee JH, Son SY, Lee CM, Ahn SH, Park DJ, Kim HH. Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy. Gastric Cancer. 2014;17(3):529\u201336. https:\/\/doi.org\/10.1007\/s10120-013-0306-2.","journal-title":"Gastric Cancer."},{"issue":"1","key":"15304_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","volume":"15","author":"F Seyfried","year":"2015","unstructured":"Seyfried F, von Rahden BH, Miras AD, et al. Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin \u2013 a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer. 2015;15(1):73. https:\/\/doi.org\/10.1186\/s12885-015-1081-8.","journal-title":"BMC Cancer."},{"issue":"1","key":"15304_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14(1):183. https:\/\/doi.org\/10.1186\/1471-2407-14-183.","journal-title":"BMC Cancer."},{"issue":"1","key":"15304_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1186\/s13063-022-06880-y","volume":"23","author":"A Di Giorgio","year":"2022","unstructured":"Di Giorgio A, Gerardi C, Abatini C, et al. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)\u2014a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO. Trials. 2022;23(1):969. https:\/\/doi.org\/10.1186\/s13063-022-06880-y.","journal-title":"Trials."},{"issue":"8","key":"15304_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/dcr.0000000000000412","volume":"58","author":"P Quere","year":"2015","unstructured":"Quere P, Facy O, Manfredi S, et al. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer. Diseases of the Colon & Rectum. 2015;58(8):743\u201352. https:\/\/doi.org\/10.1097\/dcr.0000000000000412.","journal-title":"Diseases of the Colon & Rectum."},{"issue":"12","key":"15304_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/s1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709\u201319. https:\/\/doi.org\/10.1016\/s1470-2045(16)30500-9.","journal-title":"Lancet Oncol."},{"issue":"12","key":"15304_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. British Journal of Surgery. 2002;89(12):1545\u201350. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02274.x.","journal-title":"British Journal of Surgery."},{"issue":"7","key":"15304_CR23","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1245\/s10434-023-13174-3","volume":"30","author":"I Solsky","year":"2023","unstructured":"Solsky I, Moaven O, Valenzuela CD, et al. Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease. Ann Surg Oncol. 2023;30(7):4264\u201373. https:\/\/doi.org\/10.1245\/s10434-023-13174-3.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"15304_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3(5):585\u201394. https:\/\/doi.org\/10.1002\/bjs5.50179.","journal-title":"BJS Open."},{"issue":"6120","key":"15304_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/327293a0","volume":"327","author":"JL Bos","year":"1987","unstructured":"Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327(6120):293\u20137. https:\/\/doi.org\/10.1038\/327293a0.","journal-title":"Nature."},{"issue":"6901","key":"15304_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/418934a","volume":"418","author":"H Rajagopalan","year":"2002","unstructured":"Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. RAF\/RAS oncogenes and mismatch-repair status. Nature. 2002;418(6901):934\u2013934. https:\/\/doi.org\/10.1038\/418934a.","journal-title":"Nature."},{"issue":"6","key":"15304_CR27","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1245\/s10434-021-11045-3","volume":"29","author":"M Tonello","year":"2022","unstructured":"Tonello M, Baratti D, Sammartino P, et al. Microsatellite and RAS\/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2022;29(6):3405\u201317. https:\/\/doi.org\/10.1245\/s10434-021-11045-3.","journal-title":"Ann Surg Oncol."},{"issue":"20","key":"15304_CR28","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219\u201326. https:\/\/doi.org\/10.1200\/JCO.2009.27.1825.","journal-title":"J Clin Oncol."},{"issue":"3","key":"15304_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ejca.2008.07.016","volume":"45","author":"R Jover","year":"2009","unstructured":"Jover R, Zapater P, Castells A, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009;45(3):365\u201373. https:\/\/doi.org\/10.1016\/j.ejca.2008.07.016.","journal-title":"Eur J Cancer."},{"issue":"15","key":"15304_CR30","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.3390\/cancers15153833","volume":"15","author":"M Ozer","year":"2023","unstructured":"Ozer M, Vegivinti CTR, Syed M, et al. Neoadjuvant Immunotherapy for Patients with dMMR\/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers (Basel). 2023;15(15):3833. https:\/\/doi.org\/10.3390\/cancers15153833.","journal-title":"Cancers (Basel)."},{"key":"15304_CR31","doi-asserted-by":"publisher","unstructured":"Case A, Prosser S, Peters CJ, Adams R, Gwynne S. Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative. Crit Rev Oncol Hematol. 2022;180. doi: https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103846","DOI":"10.1016\/j.critrevonc.2022.103846"},{"issue":"4","key":"15304_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/cancers15041125","volume":"15","author":"A Di Giorgio","year":"2023","unstructured":"Di Giorgio A, Macr\u00ec A, Ferracci F, et al. 10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis. Cancers (Basel). 2023;15(4):1125. https:\/\/doi.org\/10.3390\/cancers15041125.","journal-title":"Cancers (Basel)."},{"issue":"12","key":"15304_CR33","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ejso.2019.05.007","volume":"45","author":"O Sgarbura","year":"2019","unstructured":"Sgarbura O, H\u00fcbner M, Alyami M, et al. Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study. European Journal of Surgical Oncology. 2019;45(12):2386\u201391. https:\/\/doi.org\/10.1016\/j.ejso.2019.05.007.","journal-title":"European Journal of Surgical Oncology."},{"issue":"9","key":"15304_CR34","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","volume":"28","author":"KP Rovers","year":"2021","unstructured":"Rovers KP, Wassenaar ECE, Lurvink RJ, et al. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC). Ann Surg Oncol. 2021;28(9):5311\u201326. https:\/\/doi.org\/10.1245\/s10434-020-09558-4.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"15304_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","volume":"44","author":"M Nowacki","year":"2018","unstructured":"Nowacki M, Alyami M, Villeneuve L, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. European Journal of Surgical Oncology. 2018;44(7):991\u20136. https:\/\/doi.org\/10.1016\/j.ejso.2018.02.014.","journal-title":"European Journal of Surgical Oncology."},{"issue":"12","key":"15304_CR36","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1245\/s10434-023-13941-2","volume":"30","author":"M Raoof","year":"2023","unstructured":"Raoof M, Whelan RL, Sullivan KM, et al. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA. Ann Surg Oncol. 2023;30(12):7814\u201324. https:\/\/doi.org\/10.1245\/s10434-023-13941-2.","journal-title":"Ann Surg Oncol."},{"key":"15304_CR37","doi-asserted-by":"publisher","unstructured":"Grothey A, Van Cutsem E, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet. 2013;381(9863). doi:https:\/\/doi.org\/10.1016\/S0140-6736(12)61900-X","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"15304_CR38","doi-asserted-by":"publisher","unstructured":"Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer. New England Journal of Medicine. 2015;372(20). doi:https:\/\/doi.org\/10.1056\/nejmoa1414325","DOI":"10.1056\/nejmoa1414325"},{"key":"15304_CR39","doi-asserted-by":"publisher","unstructured":"Kim G, Tan HL, Sundar R, et al. PIPAC-OX: A phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases. Clinical Cancer Research. 2021;27(7). doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2152","DOI":"10.1158\/1078-0432.CCR-20-2152"},{"key":"15304_CR40","doi-asserted-by":"publisher","unstructured":"H\u00fcbner M, Alyami M, Villeneuve L, et al. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols: PIPAC practice guidelines. European Journal of Surgical Oncology. 2022;48(4). doi: https:\/\/doi.org\/10.1016\/j.ejso.2021.10.028","DOI":"10.1016\/j.ejso.2021.10.028"},{"issue":"6","key":"15304_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jso.21679","volume":"102","author":"PH Sugarbaker","year":"2010","unstructured":"Sugarbaker PH, Bijelic L, Chang D, Yoo D. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. J Surg Oncol. 2010;102(6):576\u201381. https:\/\/doi.org\/10.1002\/jso.21679.","journal-title":"J Surg Oncol."},{"issue":"5","key":"15304_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ejso.2015.01.005","volume":"41","author":"V Milovanov","year":"2015","unstructured":"Milovanov V, Sardi A, Ledakis P, et al. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). European Journal of Surgical Oncology. 2015;41(5):707\u201312. https:\/\/doi.org\/10.1016\/j.ejso.2015.01.005.","journal-title":"European Journal of Surgical Oncology."},{"issue":"4","key":"15304_CR43","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1245\/s10434-021-11153-0","volume":"29","author":"CW Mangieri","year":"2022","unstructured":"Mangieri CW, Moaven O, Valenzuela CD, et al. Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2022;29(4):2641\u20138. https:\/\/doi.org\/10.1245\/s10434-021-11153-0.","journal-title":"Ann Surg Oncol."},{"key":"15304_CR44","doi-asserted-by":"publisher","unstructured":"Grotz TE, Overman MJ, Eng C, et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Ann Surg Oncol. 2017;24(9). doi:https:\/\/doi.org\/10.1245\/s10434-017-5938-8","DOI":"10.1245\/s10434-017-5938-8"},{"issue":"12","key":"15304_CR45","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s11605-022-05423-9","volume":"26","author":"RB Morgan","year":"2022","unstructured":"Morgan RB, Yan A, Dhiman A, et al. Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS\/HIPEC. Journal of Gastrointestinal Surgery. 2022;26(12):2591\u20134. https:\/\/doi.org\/10.1007\/s11605-022-05423-9.","journal-title":"Journal of Gastrointestinal Surgery."},{"key":"15304_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jss.2022.10.085","volume":"284","author":"DN Hanna","year":"2023","unstructured":"Hanna DN, Macfie R, Ghani MO, et al. Association of Systemic Chemotherapy Approaches With Outcomes in Appendiceal Peritoneal Metastases. Journal of Surgical Research. 2023;284:94\u2013100. https:\/\/doi.org\/10.1016\/j.jss.2022.10.085.","journal-title":"Journal of Surgical Research."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15304-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:03:42Z","timestamp":1720645422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15304-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["15304"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15304-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}